# LDB1

## Overview
LDB1 (LIM domain binding 1) is a gene that encodes a nuclear adaptor protein involved in the regulation of gene expression through its interactions with LIM-homeodomain (LIM-HD) and LIM-only (LMO) proteins. The protein, also referred to as LIM domain binding 1, functions primarily as a scaffold, facilitating the assembly of transcriptional complexes that are essential for promoter-enhancer looping and gene regulation. This protein is crucial in various cellular processes, including the maintenance of differentiated states in specific cell types, such as pancreatic β cells, and plays a significant role in cellular differentiation and development across multiple tissues (Liu2019Enhancer; Ediger2016LIM). LDB1's interactions with other proteins, such as ISL1 and LMO2, underscore its importance in both normal physiological processes and pathological conditions, including cancer and developmental disorders (Lu2023LMO2; Mukhopadhyay2003Functional).

## Structure
LDB1 (LIM domain binding 1) is a nuclear adaptor protein that plays a crucial role in gene regulation by interacting with LIM-homeodomain (LIM-HD) and LIM-only (LMO) proteins. The protein contains a conserved nuclear localization sequence and is predominantly found in the nucleus (Matthews2003LIM‐domain‐binding). LDB1 has an amino-terminal homodimerization domain and a carboxy-terminal LIM interaction domain (LID), which is essential for binding LIM domains. The LID, specifically residues 300-338, is largely unstructured in solution but adopts an extended conformation upon binding to LIM domains, forming a β-strand that interacts through hydrogen bonds, hydrophobic, and electrostatic interactions (Matthews2003LIM‐domain‐binding).

The dimerization domain (DD) of LDB1 includes an N-terminal nuclear transport factor 2 (NTF2)-like subdomain and a helix 4-helix 5 subdomain, which together form the dimerization interface (Wang2019Crystal). This domain is crucial for forming complexes with LIM-HD proteins, which are important for cellular development (Matthews2003LIM‐domain‐binding). LDB1 can form homodimers via its amino-terminal region, specifically residues 1-201, which is crucial for its function (Breen1998Interactions). The protein can also be ubiquitinated by RLIM, targeting it for degradation, indicating a regulatory mechanism for its activity (Matthews2003LIM‐domain‐binding).

## Function
LIM domain-binding 1 (LDB1) is a nuclear protein that plays a critical role in transcriptional regulation by forming complexes with LIM-homeodomain (LIM-HD) proteins. It is involved in various cellular processes, including the maintenance of the terminally differentiated state of pancreatic β cells, where it is essential for normal glucose homeostasis and insulin secretion (Ediger2016LIM). LDB1 functions as a scaffold protein, facilitating the assembly of transcriptional complexes that establish promoter-enhancer looping, which is crucial for gene regulation and cell fate determination (Liu2019Enhancer).

In pancreatic β cells, LDB1 forms complexes with ISL1 and other transcription factors, co-occupying chromatin regions at active enhancers, which are marked by specific histone modifications (Ediger2016LIM). This interaction is vital for maintaining β cell identity and function, as LDB1 depletion leads to dedifferentiation and impaired insulin secretion (Ediger2016LIM).

LDB1 is also involved in enhancer-promoter interactions in other tissues, such as erythroid cells, where it facilitates the expression of critical genes like β-globin by maintaining chromatin loops (Liu2019Enhancer). Its role in these processes highlights its importance in gene regulation and cellular differentiation across various tissues.

## Clinical Significance
Mutations and alterations in the expression of the LDB1 gene have significant clinical implications, particularly in the context of cancer and developmental disorders. In acute myeloid leukemia (AML), high expression of LDB1 is associated with reduced overall survival and increased metastasis, making it a negative prognostic factor. LDB1 interacts with LMO2, forming a complex that contributes to leukemia progression, suggesting that targeting this complex could be a potential therapeutic strategy (Lu2023LMO2). In T-cell acute lymphoblastic leukemia (T-ALL), LDB1 is upregulated, correlating with poor prognosis and high tumor burden. Knockdown of LDB1 in T-ALL cell lines results in reduced proliferation and increased apoptosis, highlighting its role in disease progression (Li2024Enhancer).

LDB1 is also implicated in head and neck cancer, where its knockout leads to reduced tumor growth and angiogenesis, indicating its role in tumor promotion (Simonik2016LIMOnly). In developmental contexts, mutations in LDB1 are linked to severe patterning defects during embryogenesis, such as anterior truncation and posterior axis duplication, due to disrupted Wnt signaling pathways (Mukhopadhyay2003Functional). These findings underscore the critical role of LDB1 in both oncogenesis and embryonic development.

## Interactions
LDB1 (LIM domain binding 1) is a multi-adaptor protein that interacts with various transcription factors and cofactors, forming multiprotein complexes crucial for gene regulation. In erythroid cells, LDB1 forms complexes with LIM proteins such as LMO2, GATA1, and TAL1, facilitating enhancer-gene interactions essential for gene activation (Liu2019Enhancer). LDB1's interaction with CTCF at gene promoters also mediates enhancer-promoter interactions in erythroid genes (Liu2019Enhancer).

LDB1 interacts with LIM-homeodomain (LIM-HD) and LIM-only (LMO) proteins, playing a significant role in development. It forms complexes with nuclear LIM-domain proteins, influencing cell fate determination and organogenesis (Liu2019Enhancer). In hematopoietic cells, LDB1 forms a complex with TAL1, GATA proteins, and LMO2, crucial for erythroid differentiation (Liu2019Enhancer). In neurogenesis, LDB1 interacts with LIM-HD proteins like LHX3 and ISL1, influencing interneuron and motor neuron differentiation (Liu2019Enhancer).

LDB1's stability and interaction with LMO2 are important for maintaining the stability of LMO2 in leukemia cells. Mutant forms of LDB1 that are deficient in LMO2 binding lead to faster turnover of LMO2 (Layer2020LDB1). SSBP2 prevents RLIM-mediated degradation of LDB1 by inhibiting its ubiquitination, forming a stable trimolecular complex with LDB1 and LMO2 (Xu2007Singlestranded).


## References


[1. (Lu2023LMO2) Lihui Lu, Jianwei Wang, Fang Fang, Ailian Guo, Shuting Jiang, Yanfang Tao, Yongping Zhang, Yan Li, Kunlong Zhang, Zimu Zhang, Ran Zhuo, Xinran Chu, Xiaolu Li, Yuanyuan Tian, Li Ma, Xu Sang, Yanling Chen, Juanjuan Yu, Yang Yang, Haibo Cao, Jizhao Gao, Jun Lu, Shaoyan Hu, Jian Pan, and Hailong He. Lmo2 promotes the development of aml through interaction with transcription co-regulator ldb1. Cell Death &amp; Disease, August 2023. URL: http://dx.doi.org/10.1038/s41419-023-06039-w, doi:10.1038/s41419-023-06039-w. This article has 1 citations.](https://doi.org/10.1038/s41419-023-06039-w)

[2. (Mukhopadhyay2003Functional) Mahua Mukhopadhyay, Andreas Teufel, Tsuyoshi Yamashita, Alan D. Agulnick, Lan Chen, Karen M. Downs, Alice Schindler, Alexander Grinberg, Sing-Ping Huang, David Dorward, and Heiner Westphal. Functional ablation of the mouseldb1gene results in severe patterning defects during gastrulation. Development, 130(3):495–505, February 2003. URL: http://dx.doi.org/10.1242/dev.00225, doi:10.1242/dev.00225. This article has 128 citations and is from a peer-reviewed journal.](https://doi.org/10.1242/dev.00225)

[3. (Liu2019Enhancer) Guoyou Liu and Ann Dean. Enhancer long-range contacts: the multi-adaptor protein ldb1 is the tie that binds. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 1862(6):625–633, June 2019. URL: http://dx.doi.org/10.1016/j.bbagrm.2019.04.003, doi:10.1016/j.bbagrm.2019.04.003. This article has 22 citations.](https://doi.org/10.1016/j.bbagrm.2019.04.003)

[4. (Wang2019Crystal) Hongyang Wang, Juhyun Kim, Zhizhi Wang, Xiao-Xue Yan, Ann Dean, and Wenqing Xu. Crystal structure of human ldb1 in complex with ssbp2. Proceedings of the National Academy of Sciences, 117(2):1042–1048, December 2019. URL: http://dx.doi.org/10.1073/pnas.1914181117, doi:10.1073/pnas.1914181117. This article has 19 citations.](https://doi.org/10.1073/pnas.1914181117)

[5. (Simonik2016LIMOnly) Elizabeth A. Simonik, Ying Cai, Katherine N. Kimmelshue, Dana M. Brantley-Sieders, Holli A. Loomans, Claudia D. Andl, Grant M. Westlake, Victoria M. Youngblood, Jin Chen, Wendell G. Yarbrough, Brandee T. Brown, Lalitha Nagarajan, and Stephen J. Brandt. Lim-only protein 4 (lmo4) and lim domain binding protein 1 (ldb1) promote growth and metastasis of human head and neck cancer (lmo4 and ldb1 in head and neck cancer). PLOS ONE, 11(10):e0164804, October 2016. URL: http://dx.doi.org/10.1371/journal.pone.0164804, doi:10.1371/journal.pone.0164804. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0164804)

[6. (Xu2007Singlestranded) Zhixiong Xu, Xianzhang Meng, Ying Cai, Hong Liang, Lalitha Nagarajan, and Stephen J. Brandt. Single-stranded dna-binding proteins regulate the abundance of lim domain and lim domain-binding proteins. Genes &amp; Development, 21(8):942–955, April 2007. URL: http://dx.doi.org/10.1101/gad.1528507, doi:10.1101/gad.1528507. This article has 69 citations.](https://doi.org/10.1101/gad.1528507)

[7. (Breen1998Interactions) Joseph J. Breen, Alan D. Agulnick, Heiner Westphal, and Igor B. Dawid. Interactions between lim domains and the lim domain-binding protein ldb1. Journal of Biological Chemistry, 273(8):4712–4717, February 1998. URL: http://dx.doi.org/10.1074/jbc.273.8.4712, doi:10.1074/jbc.273.8.4712. This article has 73 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.273.8.4712)

[8. (Layer2020LDB1) Justin H. Layer, Michael Christy, Lindsey Placek, Derya Unutmaz, Yan Guo, and Utpal P. Davé. Ldb1 enforces stability on direct and indirect oncoprotein partners in leukemia. Molecular and Cellular Biology, May 2020. URL: http://dx.doi.org/10.1128/MCB.00652-19, doi:10.1128/mcb.00652-19. This article has 13 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/MCB.00652-19)

[9. (Li2024Enhancer) Yan Li, Zimu Zhang, Juanjuan Yu, Hongli Yin, Xinran Chu, Haibo Cao, Yanfang Tao, Yongping Zhang, Zhiheng Li, Shuiyan Wu, Yizhou Hu, Frank Zhu, Jizhao Gao, Xiaodong Wang, Bi Zhou, Wanyan Jiao, Yumeng Wu, Yang Yang, Yanling Chen, Ran Zhuo, Ying Yang, Fenli Zhang, Lei Shi, Yixin Hu, Jian Pan, and Shaoyan Hu. Enhancer looping protein ldb1 modulates myb expression in t-all cell lines in vitro by cooperating with master transcription factors. Journal of Experimental &amp; Clinical Cancer Research, October 2024. URL: http://dx.doi.org/10.1186/s13046-024-03199-1, doi:10.1186/s13046-024-03199-1. This article has 0 citations.](https://doi.org/10.1186/s13046-024-03199-1)

[10. (Ediger2016LIM) Benjamin N. Ediger, Hee-Woong Lim, Christine Juliana, David N. Groff, LaQueena T. Williams, Giselle Dominguez, Jin-Hua Liu, Brandon L. Taylor, Erik R. Walp, Vasumathi Kameswaran, Juxiang Yang, Chengyang Liu, Chad S. Hunter, Klaus H. Kaestner, Ali Naji, Changhong Li, Maike Sander, Roland Stein, Lori Sussel, Kyoung-Jae Won, Catherine Lee May, and Doris A. Stoffers. Lim domain–binding 1 maintains the terminally differentiated state of pancreatic β cells. Journal of Clinical Investigation, 127(1):215–229, December 2016. URL: http://dx.doi.org/10.1172/jci88016, doi:10.1172/jci88016. This article has 56 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci88016)

[11. (Matthews2003LIM‐domain‐binding) Jacqueline M Matthews and Jane E Visvader. Lim‐domain‐binding protein 1: a multifunctional cofactor that interacts with diverse proteins. EMBO reports, 4(12):1132–1137, December 2003. URL: http://dx.doi.org/10.1038/sj.embor.7400030, doi:10.1038/sj.embor.7400030. This article has 133 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/sj.embor.7400030)